Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Generic Clearance for the Collection of Quantitative Data on Tobacco Products and Communications, 70873-70875 [2014-28106]
Download as PDF
<![CDATA[
70873
Federal Register / Vol. 79, No. 229 / Friday, November 28, 2014 / Notices
Island; Megan Padden, Vice President,
Sentara Health Plans; Jeanne Ryer,
Director, New Hampshire Citizens
Health Initiative, University of New
Hampshire; Carla Smith, Executive Vice
President, Healthcare Information and
Management Systems Society (HIMSS);
Winston Wong, Medical Director,
Community Benefit Director, Kaiser
Permanente and Darlene Yee-Melichar,
Professor & Coordinator, San Francisco
State University.
The agenda for the December 15, 2014
meeting will include the following:
• Welcome and listening session with
CMS leadership
• Recap of the previous (May 22, 2014)
meeting
• Affordable Care Act initiatives
• An opportunity for public comment
• Meeting summary, review of
recommendations and next steps
Individuals or organizations that wish
to make a 5-minute oral presentation on
an agenda topic should submit a written
copy of the oral presentation to the DFO
at the address listed in the ADDRESSES
section of this notice by the date listed
in the DATES section of this notice. The
number of oral presentations may be
limited by the time available.
Individuals not wishing to make an oral
presentation may submit written
comments to the DFO at the address
listed in the ADDRESSES section of this
notice by the date listed in the DATES
section of this notice.
Authority: Sec. 222 of the Public Health
Service Act (42 U.S.C. 217a) and sec. 10(a)
of Pub. L. 92–463 (5 U.S.C. App. 2, sec. 10(a)
and 41 CFR 102–3).
Dated: November 25, 2014.
Marilyn Tavenner,
Administrator, Centers for Medicare &
Medicaid Services.
[FR Doc. 2014–28217 Filed 11–26–14; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Notice of Allotment Percentages to
States for Child Welfare Services State
Grants
Administration on Children,
Youth and Families, Administration for
Children and Families, Department of
Health and Human Services.
ACTION: Biennial publication of
allotment percentages for States under
the Title IV–B subpart 1, Child Welfare
Services State Grants Program (CFDA
No. 93.645).
tkelley on DSK3SPTVN1PROD with NOTICES
AGENCY:
VerDate Sep<11>2014
16:58 Nov 26, 2014
Jkt 235001
As required by section 423(c)
of the Social Security Act (42 U.S.C.
623(c)), the Department is publishing
the allotment percentage for each State
under the Title IV–B Subpart 1, Child
Welfare Services State Grants Program.
Under section 423(a), the allotment
percentages are one of the factors used
in the computation of the Federal grants
awarded under the Program.
DATES: Effective Dates: The allotment
percentages shall be effective for Fiscal
Years 2016 and 2017.
FOR FURTHER INFORMATION CONTACT:
Deborah Bell, Grants Fiscal Management
Specialist, Office of Grants
Management, Office of Administration,
Administration for Children and
Families, telephone (202) 401–4611.
SUPPLEMENTARY INFORMATION: The
allotment percentage for each State is
determined on the basis of paragraphs
(b) and (c) of section 423 of the Act.
These figures are available on the ACF
homepage on the internet: https://
www.acf.dhhs.gov/programs/cb/. The
allotment percentage for each State is as
follows:
SUMMARY:
Allotment
percentage
State
Alabama ....................................
Alaska .......................................
Arizona ......................................
Arkansas ...................................
California ...................................
Colorado ...................................
Connecticut ...............................
Delaware ...................................
District of Columbia ..................
Florida .......................................
Georgia .....................................
Hawaii .......................................
Idaho .........................................
Illinois ........................................
Indiana ......................................
Iowa ..........................................
Kansas ......................................
Kentucky ...................................
Louisiana ..................................
Maine ........................................
Maryland ...................................
Massachusetts ..........................
Michigan ...................................
Minnesota .................................
Mississippi ................................
Missouri ....................................
Montana ....................................
Nebraska ..................................
Nevada .....................................
New Hampshire ........................
New Jersey ...............................
New Mexico ..............................
New York ..................................
North Carolina ..........................
North Dakota ............................
Ohio ..........................................
Oklahoma .................................
Oregon ......................................
Pennsylvania ............................
Rhode Island ............................
South Carolina ..........................
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
59.09
43.55
58.45
59.17
46.42
47.68
32.05
49.91
14.17
53.25
57.54
49.44
60.03
47.77
56.92
49.95
50.53
59.39
54.18
54.46
39.19
35.95
56.28
46.65
62.12
54.83
56.05
47.91
55.86
43.36
37.68
59.43
38.88
56.69
40.07
54.34
53.45
55.52
48.37
47.52
59.92
State
Allotment
percentage
South Dakota ............................
Tennessee ................................
Texas ........................................
Utah ..........................................
Vermont ....................................
Virginia ......................................
Washington ...............................
West Virginia ............................
Wisconsin .................................
Wyoming ...................................
American Samoa ......................
Guam ........................................
N. Mariana Islands ...................
Puerto Rico ...............................
Virgin Islands ............................
48.15
55.94
51.20
59.34
49.39
44.92
46.94
60.16
51.83
41.14
70.00
70.00
70.00
70.00
70.00
Christopher Beach,
Senior Grants Policy Specialist, Division of
Grants Policy, Office of Administration.
[FR Doc. 2014–28135 Filed 11–26–14; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–0987]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Generic Clearance
for the Collection of Quantitative Data
on Tobacco Products and
Communications
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by December
29, 2014.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–NEW and
title ‘‘Generic Clearance for the
Collection of Quantitative Data on
Tobacco Products and
Communications.’’ Also include the
FDA docket number found in brackets
in the heading of this document.
SUMMARY:
E:\FR\FM\28NON1.SGM
28NON1
70874
Federal Register / Vol. 79, No. 229 / Friday, November 28, 2014 / Notices
FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 8455
Colesville Rd., COLE–14526, Silver
Spring, MD 20993–0002,
PRAStaff@fda.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUPPLEMENTARY INFORMATION:
Generic Clearance for the Collection of
Quantitative Data on Tobacco Products
and Communications—(OMB Control
Number 0910—NEW)
In order to conduct educational and
public information programs relating to
tobacco use as authorized by section
1003(d)(2)(D) of the Federal Food, Drug,
and Cosmetic Act (21 U.S.C.
393(d)(2)(D)), FDA’s Center for Tobacco
Products (CTP) will create and use a
variety of media to inform and educate
the public, tobacco retailers, and health
professionals about the risks of tobacco
use, how to quit using tobacco products,
and FDA’s role in regulating tobacco.
To ensure that these health
communication messages have the
highest potential to be received,
understood, and accepted by those for
whom they are intended, the Center for
Tobacco Products will conduct research
and studies relating to the control and
prevention of disease. In conducting
such research, FDA will employ
formative pretests. Formative pretests
are conducted on a small scale, and
their focus is on developing and
assessing the likely effectiveness of
communications with specific target
audiences. This type of research
involves: (1) Assessing audience
knowledge, attitudes, behaviors, and
other characteristics for the purpose of
determining the need for and
developing health messages,
communication strategies, and public
information programs and (2) pretesting
these health messages, strategies, and
program components while they are in
developmental form to assess audience
comprehension, reactions, and
perceptions.
Formative pretesting is a staple of best
practices in communications research.
Obtaining feedback from intended
audiences during the development of
messages and materials is crucial for the
success of every communication
program. The purpose of obtaining
information from formative pretesting is
that it allows FDA to improve materials
and strategies while revisions are still
affordable and possible. Formative
pretesting can also avoid potentially
expensive and dangerous unintended
outcomes caused by audiences’
interpreting messages in a way that was
not intended by the drafters. By
maximizing the effectiveness of
messages and strategies for reaching
targeted audiences, the frequency with
which tobacco communication messages
need to be modified should be greatly
reduced.
The information collected will serve
the primary purpose of providing FDA
information about the perceived
effectiveness of messages,
advertisements, and materials in
reaching and successfully
communicating with their intended
audiences. Quantitative testing
messages and other materials with a
sample of the target audience will allow
FDA to refine messages, advertisements,
and materials, including questionnaires
or images, directed at consumers while
the materials are still in the
developmental stage.
In the Federal Register of July 17,
2014 (79 FR 41696), FDA published a
60-day notice requesting public
comment on the proposed collection of
information. Four comments were
received, but only two comments were
PRA-related.
(Comment 1) One comment was
supportive of the information collection,
stating they ‘‘support CTP’s proposal to
conduct formative pretests to ensure
that health communication messages are
received, understood and accepted by
the intended audiences’’ and that they
believe the proposed information
collection is necessary and will have
practical utility. The comment also
stated that CTP’s projection of the
burden of the proposed collection effort
seems reasonable. In addition, the
comment suggested that FDA consult
with FDA’s Risk Communication
Advisory Committee on proposed
information collections.
(Response) FDA agrees that the
request in this collection of information
is necessary and that the proposed
burden is reasonable. Consultation with
other U.S. Department of Health and
Human Services (HHS) Agencies, FDA
advisory committees, and/or the public
will occur when appropriate.
(Comment 2) One comment was
supportive of the data collection stating
that the ‘‘collections are, in fact,
essential.’’ That comment also made
suggestions about what the specific
goals of messages tested in information
collections included under this generic
collection should focus on, and
suggested that those collections be made
available for further public comments.
(Response) FDA agrees that the
request in this collection of information
is essential to the mission of FDA as a
science-based Agency in its
implementation of the Tobacco Control
Act. Although we appreciate
suggestions for the content of future
submissions submitted under this
generic clearance, ultimately such
decisions will be driven by needs
determined by the Agency in
consultation with other HHS Agencies
and the public when appropriate.
FDA estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Activity
Number of
respondents
Number of
responses per
respondent
Total annual
responses
Average burden per
response
Total hours
Self-Administered Surveys .......................................
30,300
1
30,300
0.33 (20 minutes) ......
9,999
tkelley on DSK3SPTVN1PROD with NOTICES
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
The number of respondents to be
included in each new survey will vary,
depending on the nature of the material
or message being tested and the target
audience.
Dated: November 20, 2014.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2014–28106 Filed 11–26–14; 8:45 am]
BILLING CODE 4164–01–P
VerDate Sep<11>2014
17:31 Nov 26, 2014
Jkt 235001
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
E:\FR\FM\28NON1.SGM
28NON1
Federal Register / Vol. 79, No. 229 / Friday, November 28, 2014 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–1904]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Comparing Food
Safety Knowledge, Attitude, and
Behavior Among English-Dominant
Hispanics, Spanish-Dominant
Hispanics, and Other Consumers
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or we) is
announcing an opportunity for public
comment on our proposed collection of
certain information. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal Agencies must publish a
notice in the Federal Register
concerning each proposed collection of
information and allow 60 days for
public comment. This notice invites
comments on the proposed data
collection entitled ‘‘Comparing Food
Safety Knowledge, Attitude, and
Behavior Among English-Dominant
Hispanics, Spanish-Dominant
Hispanics, and Other Consumers.’’
DATES: Submit either electronic or
written comments on the collection of
information by January 27, 2015.
ADDRESSES: Submit electronic
comments on the collection of
information to https://
www.regulations.gov. Submit written
comments on the collection of
information to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. All
comments should be identified with the
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT: FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 8455
Colesville Rd., COLE–14526, Silver
Spring, MD 20993–0002, PRAStaff@
fda.hhs.gov.
SUMMARY:
SUPPLEMENTARY INFORMATION:
tkelley on DSK3SPTVN1PROD with NOTICES
I. Background
Under the PRA (44 U.S.C. 3501–
3520), Federal Agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
VerDate Sep<11>2014
17:31 Nov 26, 2014
Jkt 235001
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
Agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information
before submitting the collection to OMB
for approval. To comply with this
requirement, we are publishing this
notice of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, we invite
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of our functions, including whether the
information will have practical utility;
(2) the accuracy of our estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(3) ways to enhance the quality, utility,
and clarity of the information to be
collected; and (4) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques,
when appropriate, and other forms of
information technology.
Comparing Food Safety Knowledge,
Attitude, and Behavior Among EnglishDominant Hispanics, SpanishDominant Hispanics, and Other
Consumers—(OMB Control Number
0910—NEW)
We conduct research and educational
and public information programs
relating to food safety and nutrition
under our broad statutory authority, set
forth in section 903(b)(2) of the Federal
Food, Drug, and Cosmetic Act (FD&C
Act) (21 U.S.C. 393(b)(2)), to protect the
public health by ensuring that foods are
‘‘safe, wholesome, sanitary, and
properly labeled,’’ and in section
903(d)(2)(C) of the FD&C Act (21 U.S.C.
393(d)(2)(C)), to conduct research
relating to foods, drugs, cosmetics, and
devices.
Our current food safety education and
outreach programs and materials
generally are developed and provided
for the English-speaking population in
the United States (Ref. 1). To better
protect public health and to help
consumers practice safe food handling,
we need empirical data on how different
population groups understand, perceive,
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
70875
and practice food safety and food
handling. An emerging and important
demographic trend in the United States
is the increase in Hispanics. Recent
estimates suggest that Hispanics
(defined as those who identify
themselves as of Hispanic or Latino
origin) are the largest and fastest
growing minority group in the nation;
the proportion of the U.S. population
that was Hispanic was 14 percent in
2005 and is projected to increase to 29
percent in 2050 (Ref. 2).
Data from the Centers for Disease
Control and Prevention indicate that, in
the past two decades, Hispanics were
one of the population groups that often
experienced higher incidence rates (per
100,000 population) of bacterial causes
of foodborne illness than Caucasians
(Ref. 3). These bacterial causes include
Campylobacter, Listeria monocytogenes,
Shigella, and Salmonella. While some
Hispanics living in the United States
use the English language exclusively, or
more often than Spanish (Englishdominant Hispanics), other U.S.
Hispanics predominantly use the
Spanish language in their daily lives
(Spanish-dominant Hispanics) (Ref. 4).
Since most U.S. food labels, including
safe food handling instructions, are in
English, Spanish-dominant Hispanics’
understanding and use of safe food
handling instructions may differ from
that of English-dominant Hispanics and
of non-Hispanics who use English
exclusively. In addition, Hispanics may
have certain food handling practices
that may increase their risk of foodborne
illness (Ref. 5).
FDA needs an understanding of how
different population groups perceive
and behave in terms of food safety and
food handling to inform possible
measures that we may take to better
protect public health and to help
consumers practice safe food handling.
FDA is aware of no consumer research
on a nationwide level on how different
population groups understand, perceive,
and practice food safety and food
handling. This study is intended to
provide answers to research questions
such as whether and how much
Spanish-dominant Hispanics, Englishdominant Hispanics, and Englishspeaking non-Hispanics differ in their
knowledge, attitude, and behavior
toward food safety and food handling
among the three population groups, and
the role that demographic and other
factors may play in any differences.
The proposed study will use a Webbased instrument to collect information
E:\FR\FM\28NON1.SGM
28NON1
]]>Agencies
[Federal Register Volume 79, Number 229 (Friday, November 28, 2014)]
[Notices]
[Pages 70873-70875]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-28106]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2014-N-0987]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Generic Clearance for
the Collection of Quantitative Data on Tobacco Products and
Communications
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.
DATES: Fax written comments on the collection of information by
December 29, 2014.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
FAX: 202-395-7285, or emailed to oira_submission@omb.eop.gov. All
comments should be identified with the OMB control number 0910-NEW and
title ``Generic Clearance for the Collection of Quantitative Data on
Tobacco Products and Communications.'' Also include the FDA docket
number found in brackets in the heading of this document.
[[Page 70874]]
FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations,
Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver
Spring, MD 20993-0002, PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
Generic Clearance for the Collection of Quantitative Data on Tobacco
Products and Communications--(OMB Control Number 0910--NEW)
In order to conduct educational and public information programs
relating to tobacco use as authorized by section 1003(d)(2)(D) of the
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 393(d)(2)(D)), FDA's
Center for Tobacco Products (CTP) will create and use a variety of
media to inform and educate the public, tobacco retailers, and health
professionals about the risks of tobacco use, how to quit using tobacco
products, and FDA's role in regulating tobacco.
To ensure that these health communication messages have the highest
potential to be received, understood, and accepted by those for whom
they are intended, the Center for Tobacco Products will conduct
research and studies relating to the control and prevention of disease.
In conducting such research, FDA will employ formative pretests.
Formative pretests are conducted on a small scale, and their focus is
on developing and assessing the likely effectiveness of communications
with specific target audiences. This type of research involves: (1)
Assessing audience knowledge, attitudes, behaviors, and other
characteristics for the purpose of determining the need for and
developing health messages, communication strategies, and public
information programs and (2) pretesting these health messages,
strategies, and program components while they are in developmental form
to assess audience comprehension, reactions, and perceptions.
Formative pretesting is a staple of best practices in
communications research. Obtaining feedback from intended audiences
during the development of messages and materials is crucial for the
success of every communication program. The purpose of obtaining
information from formative pretesting is that it allows FDA to improve
materials and strategies while revisions are still affordable and
possible. Formative pretesting can also avoid potentially expensive and
dangerous unintended outcomes caused by audiences' interpreting
messages in a way that was not intended by the drafters. By maximizing
the effectiveness of messages and strategies for reaching targeted
audiences, the frequency with which tobacco communication messages need
to be modified should be greatly reduced.
The information collected will serve the primary purpose of
providing FDA information about the perceived effectiveness of
messages, advertisements, and materials in reaching and successfully
communicating with their intended audiences. Quantitative testing
messages and other materials with a sample of the target audience will
allow FDA to refine messages, advertisements, and materials, including
questionnaires or images, directed at consumers while the materials are
still in the developmental stage.
In the Federal Register of July 17, 2014 (79 FR 41696), FDA
published a 60-day notice requesting public comment on the proposed
collection of information. Four comments were received, but only two
comments were PRA-related.
(Comment 1) One comment was supportive of the information
collection, stating they ``support CTP's proposal to conduct formative
pretests to ensure that health communication messages are received,
understood and accepted by the intended audiences'' and that they
believe the proposed information collection is necessary and will have
practical utility. The comment also stated that CTP's projection of the
burden of the proposed collection effort seems reasonable. In addition,
the comment suggested that FDA consult with FDA's Risk Communication
Advisory Committee on proposed information collections.
(Response) FDA agrees that the request in this collection of
information is necessary and that the proposed burden is reasonable.
Consultation with other U.S. Department of Health and Human Services
(HHS) Agencies, FDA advisory committees, and/or the public will occur
when appropriate.
(Comment 2) One comment was supportive of the data collection
stating that the ``collections are, in fact, essential.'' That comment
also made suggestions about what the specific goals of messages tested
in information collections included under this generic collection
should focus on, and suggested that those collections be made available
for further public comments.
(Response) FDA agrees that the request in this collection of
information is essential to the mission of FDA as a science-based
Agency in its implementation of the Tobacco Control Act. Although we
appreciate suggestions for the content of future submissions submitted
under this generic clearance, ultimately such decisions will be driven
by needs determined by the Agency in consultation with other HHS
Agencies and the public when appropriate.
FDA estimates the burden of this collection of information as
follows:
Table 1--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of
Activity Number of responses per Total annual Average burden per response Total hours
respondents respondent responses
--------------------------------------------------------------------------------------------------------------------------------------------------------
Self-Administered Surveys................. 30,300 1 30,300 0.33 (20 minutes)....................... 9,999
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
The number of respondents to be included in each new survey will
vary, depending on the nature of the material or message being tested
and the target audience.
Dated: November 20, 2014.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2014-28106 Filed 11-26-14; 8:45 am]
BILLING CODE 4164-01-P
